Skip to content
LIQUIDIA26 5

Drawing based on the label description. No photo yet.

LIQUIDIA 26 5 pill

Pill with imprint LIQUIDIA 26 5 is yellow, capsule, 16 mm and has been identified as Treprostinil 26.5 mcg. It is used for high blood pressure in the lungs. It is supplied by Liquidia Technologies, Inc.

Treprostinil 26.5 mcg

Imprint
LIQUIDIA 26 5
Strength
26.5 mcg
Used for
High blood pressure in the lungs
Color
Yellow
Shape
Capsule / oblong
Size
16 mm
Score
No score line
Form
Capsule
Manufacturer
Liquidia Technologies, Inc
Drug class
Prostacycline vasodilator
NDC
72964-011, 72964-011-01

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Treprostinil pills and guides

What is Treprostinil used for?

Treprostinil is used for high blood pressure in the lungs.

Medicine type
Prostacycline vasodilator
Official uses from the US prescribing label

Pulmonary Arterial Hypertension

YUTREPIA is indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately included patients with NYHA Functional Class III symptoms and etiologies of idiopathic or heritable PAH (56%) or PAH associated with connective tissue diseases (33%).

The effects diminish over the minimum recommended dosing interval of 4 hours; treatment timing can be adjusted for planned activities.

While there are long-term data on use of treprostinil by other routes of administration, nearly all controlled clinical experience with inhaled treprostinil has been on a background of bosentan (an endothelin receptor antagonist) or sildenafil (a phosphodiesterase type 5 inhibitor). The controlled clinical experience was limited to 12 weeks in duration.

Pulmonary Hypertension Associated with ILD

YUTREPIA is indicated for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. The study establishing effectiveness predominately included patients with etiologies of idiopathic interstitial pneumonia (IIP) (45%) inclusive of idiopathic pulmonary fibrosis (IPF), combined pulmonary fibrosis and emphysema (CPFE) (25%), and WHO Group 3 connective tissue disease (22%).

From the FDA-approved label on DailyMed (published Sep 10, 2025).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows LIQUIDIA 26 5. The parts can be split between the two sides, so turn the pill over and check both.
  • It is yellow, capsule, 16 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Yutrepia.

Ingredients

Active: Treprostinil Sodium

Inactive: Trehalose Dihydrate, Polysorbate 80, Leucine, Trisodium Citrate Dihydrate, Sodium Chloride

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Treprostinil pills